Browsing by Author "García Ariza, Miguel"
Now showing items 1-2 of 2
-
Clinical management of the acute complications of sickle cell anemia: 11 years of experience in a tertiary hospital
Reparaz Goñi, Patricia; Serrano Pejenaute, Idoya; Adán Pedroso, Rosa; Astigarraga Aguirre, María Iciar; De Pedro Olabarri, Jimena; Echebarria Barona, Aizpea Beatriz; García Ariza, Miguel; López Almaraz, Ricardo; Del Orbe Barreto, Rafael Andrés; Vara Pampliega, Miriam; González Urdiales, Paula (Elsevier, 2022-07)Sickle cell disease is an emerging anemia in Europe leading to high morbidity with severe acute complications requiring hospital admission and chronic consequences. The management of these patients is complex and needs ... -
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
Goddard, Jack; Castle, Jemma; Southworth, Emily; Fletcher, Anya; Crosier, Stephen; Martín Guerrero, Idoia; García Ariza, Miguel; Navajas Gutiérrez, Aurora; Masliah-Planchon, Julien; Bourdeaut, Franck; Dufour, Christelle; Ayrault, Olivier; Goschzik, Tobias; Pietsch, Torsten; Sill, Martin; Pfister, Stefan M; Rutkowski, Stefan; Richardson, Stacey; Hill, Rebecca M; Williamson, Daniel; Bailey, Simon; Schwalbe, Edward C; Clifford, Steven; Hicks, Debbie (Springer, 2023-05)Group 4 tumours (MBGrp4) represent the majority of non-WNT/non-SHH medulloblastomas. Their clinical course is poorly predicted by current risk-factors. MBGrp4 molecular substructures have been identified (e.g. subgroups/ ...